Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Vacunas (English Edition)
Adverse events following COVID-19 vaccination among pregnant women attending primary health centers: An active-surveillance study
Narayana Goruntla, Basappa Karisetty, Nandini Nandini, Bharadwaj Bhupasamudram, Himaja Reddy Gangireddy, Kasturi Vishwanathasetty Veerabhadrappa, Joseph Obiezu Chukwujekwu Ezeonwumelu, Vishnuvandana Bandaru
10.1016/j.vacune.2023.05.002
Vacunas. 2023;24:291-7
Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria
de Arriba Fernandez, José Luis Alonso Bilbao, Frances, Antonio Cabeza Mora, Perez, Miguel Ángel Díaz Barreiros
10.1016/j.vacune.2023.06.004
Vacunas. 2023;24:308-16
Exploring the intention and hesitancy to receive a booster dose of COVID-19 vaccine among patients with comorbid disease conditions using a health belief model
Anmar Al-Taie, Zekiye Yilmaz
10.1016/j.vacune.2023.06.005
Vacunas. 2023;24:317-25
COVID vaccine: Social, menstrual and psychological aftermath
Swati Gupta, Divya Rai, Shipra Shukla
10.1016/j.vacune.2023.10.007
Vacunas. 2023;24:326-34
Impact of vaccination in the mortality of Colombian adults with acute respiratory distress syndrome due to SARS-CoV-2 who required invasive mechanical ventilation
Yina Daniela Benítez Patiño, Luis Carlos Triana, Oscar Mauricio Muñoz Velandia, Viviana Yiset López Ramírez, Laura María Niño Guerra, Santiago Bottia Córdoba
10.1016/j.vacune.2023.10.002
Vacunas. 2023;24:335-40
COVID-19 immune response in adults post Measles-Rubella vaccination
Suwoyo Suwoyo, Erna Rahma Yani, Koekoeh Hardjito
10.1016/j.vacune.2023.10.008
Vacunas. 2023;24:341-7
Immuno-informatics design of a multimeric epitope peptide-based vaccine against dengue virus serotype-2
Mohamed Sheik Tharik Abdul Azeeze, Rajaguru Arivuselvam
10.1016/j.vacune.2023.10.012
Vacunas. 2023;24:380-93
Autoimmune diseases related to post-SARS-CoV-2 vaccination: A rheumatology perspective
Farhad Dadgar, Jorge Casseb, Masoud Keikha
10.1016/j.vacune.2023.10.013
Vacunas. 2023;24:400-1
To assess mortality from COVID-19 in patients with comorbidities, it is crucial to perform an autopsy
Josef Finsterer
10.1016/j.vacune.2023.10.015
Vacunas. 2023;24:404-5
The end of COVID-19 public health emergency of international concern (PHEIC): And now what?
Núria Torner
10.1016/j.vacune.2023.05.001
Vacunas. 2023;24:164-5